IP Verse

Par Pharmaceutical competitive analysis

Latest publications and patents of Par Pharmaceutical New

Explore the latest publications and patents granted to Par Pharmaceutical, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Par Pharmaceutical

Discover the latest PTAB cases involving Par Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Par Pharmaceutical

IPR2018-01550Aug 21, 2018PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01768Jul 13, 2017PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01769Jul 13, 2017PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01767Jul 13, 2017PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01557Jun 9, 2017PAR PHARMACEUTICALMONOSOL RXInstitution Denied
IPR2017-01292Apr 18, 2017PAR PHARMACEUTICALSUMITOMO DAINIPPON PHARMATerminated-Settled
IPR2016-01479Jul 22, 2016PAR PHARMACEUTICALNOVARTISFinal Written Decision
IPR2016-01059May 17, 2016PAR PHARMACEUTICALNOVARTISInstitution Denied
IPR2016-00078Oct 26, 2015PAR PHARMACEUTICALNOVARTISInstitution Denied
IPR2016-00084Oct 26, 2015PAR PHARMACEUTICALNOVARTISFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Par Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
PAR PHARMACEUTICAL - - 21 - Highly Aggressive
HORIZON THERAPEUTICS - - - 12Non-Active
JAZZ PHARMACEUTICALS - - - 23Non-Active
NOVARTIS6406 - 21Defensive